Brain-health pharma with 70+ years in neuroscience, expanding rare-disease and specialty treatments globally.
Lundbeck is a Copenhagen-based biopharmaceutical company with 5,000+ employees across 20+ countries, focused on neurological and psychiatric diseases where treatment options are scarce. The tech stack reflects a traditional pharma operations footprint—Veeva CRM, SAP, Salesforce, ServiceNow, Veeva LIMS—paired with modern data tooling (Snowflake, dbt, Python, Terraform), suggesting active investment in analytics and data infrastructure. Hiring velocity is accelerating across sales (77 open roles), healthcare operations (15), and finance (11), with a concentration in mid-level roles, signaling scaled commercial and regulatory execution rather than R&D ramp.
Notable leadership hires: Migraine zone director, Regional Business Director, Marketing Director
Lundbeck develops transformative medicines for neurological and psychiatric conditions, targeting patient populations with few or no existing treatment options. The company operates across psychiatry, neurology, and emerging neuro-specialty and neuro-rare segments, with products available in over 80 countries. Operating challenges center on commercialization, payer access, regulatory compliance, and global platform scaling—typical friction points for multinational pharma expanding into rare-disease markets. The organization balances legacy psychiatry/neurology expertise with newer specialty care expansion, reflected in active projects around product registration, reimbursement support, and regional trial work.
Lundbeck uses Veeva CRM, SAP, Salesforce, ServiceNow, Veeva LIMS, Snowflake, dbt, Python, Terraform, Power BI, and Microsoft Office suite. The mix indicates integrated ERP/CRM operations with modern data and infrastructure tools.
Lundbeck specializes in brain health, with 70+ years in neuroscience. Current focus areas include schizophrenia, psychosis, Parkinson's disease, Alzheimer's disease, and depression, plus newer work in neuro-specialty and neuro-rare disease segments.
Other companies in the same industry, closest in size